•
Dec 31, 2021

Lyell Immunopharma Q4 2021 Earnings Report

Total Revenue
$2.82M
Previous year: $2.31M
+22.1%
EPS
-$0.17
Previous year: -$15.7
-98.9%
Gross Profit
-$1.17M
Previous year: $2.31M
-150.5%
Cash and Equivalents
$294M
Previous year: $140M
+109.3%
Free Cash Flow
-$43.4M
Previous year: -$51.6M
-15.8%
Total Assets
$1.13B
Previous year: $908M
+24.1%

Lyell Immunopharma

Lyell Immunopharma